UnknownNot Applicable

Impact of Number of Rank of B-lactam Antibiotics on Emergence on Multidrug Resistant Bacteria

1,300 participantsStarted 2019-01-01

Plain-language summary

This study evaluates the impact of rank of Beta lactam antibiotics on emergence of mutlidrug resistant bacteria colonization in intensive care It's retrospective case controle study. Cases are colonized patient by multidrug resistant bacteria hospitalized in intensive care during the fist hospitalization in intensive care. Temoin are patients with the same characteristics than case but no colonized by multidrug resistant bacteria.

Who can participate

Age range18 Years – 100 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * all patient hospitalized more than 48 hours in intensive care unit in Besançon between january 2016 and december 2017 Exclusion Criteria: * patient under guardianship * patient allergic to Beta lactam * colonization with mutidrug resistant the first week of hospitalization in intensive care unit

What they're measuring

number of Beta lactam class prescription

Timeframe: 3 months

Trial details

NCT IDNCT03752476

SponsorCentre Hospitalier Universitaire de Besancon

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2019-05-01

Contact for this trial

ESTELLE DOSSOT

+33645578372 estelle.dossot@gmail.com

View on ClinicalTrials.gov More Resistant Infection trials